Kathy Castor said...
Where do we draw the line? Because I think as legislation is developed, and your testimony is that you do not want and it is not appropriate to capture the community pharmacists who are compounding.
Context
Castor seeks clarity on legislation regarding community pharmacists and large-scale manufacturers.
05/22/2013